TRZLX
Price
$42.64
Change
+$0.37 (+0.88%)
Updated
Jun 6 closing price
Net Assets
19.05B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

TRZLX vs VITSX

Header iconTRZLX vs VITSX Comparison
Open Charts TRZLX vs VITSXBanner chart's image
T. Rowe Price US Large-Cap Core Z
Price$42.64
Change+$0.37 (+0.88%)
VolumeN/A
Net Assets19.05B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
TRZLX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. TRZLX (19B). VITSX pays higher dividends than TRZLX: VITSX (1.29) vs TRZLX (1.14). TRZLX was incepted earlier than VITSX: TRZLX (5 years) vs VITSX (28 years). TRZLX (0.54) is less costly to investors than VITSX (0.03). TRZLX is a more actively managed with annual turnover of: 58.40 vs. VITSX (2.00). TRZLX has a lower initial minimum investment than VITSX: TRZLX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. TRZLX (2.12). VITSX return over 5 years is better than : 80.96 vs. TRZLX (68.79).
TRZLXVITSXTRZLX / VITSX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.540.031,800%
Fund Existence5 years28 years-
Gain YTD2.3240.833279%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets19B1.82T1%
Annual Yield % from dividends1.141.2989%
Returns for 1 year2.1210.9719%
Returns for 3 years37.9540.3594%
Returns for 5 years68.7980.9685%
Returns for 10 yearsN/A180.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.